Background:

Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. May play a role in tumor suppression.

Applications:

WB

Name of antibody:

MN1

Immunogen:

Synthesized peptide derived from internal of human MN1.

Full name:

meningioma (disrupted in balanced translocation) 1

Synonyms：

MGCR; MGCR1; MGCR1-PEN; dJ353E16.2

SwissProt:

Q10571

WB Predicted band size:

136 kDa

WB Positive control:

COLO cells lysate

WB Recommended dilution:

500-3000